Trial intelligence / Profile preview

Effect of Single Dose Imipramine on Urethral and Anal Sphincter in Healthy Women

NCT03102645Phase 1Completed

Start
May 2017
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in stress urinary incontinence (SUI) and fecal incontinence (FI) comparing Imipramine first with Placebo first (2 arms). Primary endpoint: Urethral Opening Pressure at 1 hour. Started May 2017; status: completed.

02

Drugs

imipramine
03

Conditions

stress urinary incontinence (SUI)fecal incontinence (FI)

Beyond the preview

Go deeper on NCT03102645.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03102645.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call